A detailed history of Financial Management Professionals, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 7,276 shares of GILD stock, worth $695,512. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,276
Previous 6,389 13.88%
Holding current value
$695,512
Previous $536,000 25.37%
% of portfolio
0.09%
Previous 0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

BUY
$83.95 - $97.9 $74,463 - $86,837
887 Added 13.88%
7,276 $672,000
Q3 2024

Oct 24, 2024

BUY
$66.59 - $83.99 $6,126 - $7,727
92 Added 1.46%
6,389 $536,000
Q2 2024

Jul 12, 2024

BUY
$63.15 - $72.88 $26,459 - $30,536
419 Added 7.13%
6,297 $432,000
Q1 2024

Apr 16, 2024

BUY
$71.58 - $87.29 $25,840 - $31,511
361 Added 6.54%
5,878 $431,000
Q4 2023

Jan 12, 2024

BUY
$73.27 - $83.09 $41,910 - $47,527
572 Added 11.57%
5,517 $447,000
Q3 2023

Oct 13, 2023

BUY
$73.94 - $80.67 $46,286 - $50,499
626 Added 14.49%
4,945 $371,000
Q2 2023

Jul 10, 2023

BUY
$76.01 - $86.7 $15,049 - $17,166
198 Added 4.8%
4,319 $333,000
Q1 2023

Apr 13, 2023

SELL
$77.31 - $88.08 $79,629 - $90,722
-1,030 Reduced 20.0%
4,121 $342,000
Q4 2022

Jan 11, 2023

BUY
$62.32 - $89.47 $44,309 - $63,613
711 Added 16.01%
5,151 $442,000
Q3 2022

Oct 27, 2022

BUY
$59.54 - $68.01 $19,231 - $21,967
323 Added 7.85%
4,440 $274,000
Q2 2022

Jul 12, 2022

BUY
$57.72 - $65.01 $33,766 - $38,030
585 Added 16.56%
4,117 $254,000
Q1 2022

Apr 27, 2022

BUY
$57.92 - $72.58 $70,604 - $88,475
1,219 Added 52.7%
3,532 $210,000
Q4 2021

Jan 28, 2022

BUY
$64.88 - $73.64 $6,747 - $7,658
104 Added 4.71%
2,313 $168,000
Q3 2021

Nov 02, 2021

SELL
$67.69 - $73.03 $744 - $803
-11 Reduced 0.5%
2,209 $154,000
Q2 2021

Aug 05, 2021

BUY
$63.47 - $69.35 $36,495 - $39,876
575 Added 34.95%
2,220 $153,000
Q1 2021

Apr 26, 2021

BUY
$60.0 - $68.46 $7,260 - $8,283
121 Added 7.94%
1,645 $106,000
Q4 2020

Feb 03, 2021

BUY
$56.65 - $64.55 $2,492 - $2,840
44 Added 2.97%
1,524 $89,000
Q3 2020

Oct 26, 2020

BUY
$62.1 - $78.08 $683 - $858
11 Added 0.75%
1,480 $94,000
Q2 2020

Jul 21, 2020

BUY
$72.34 - $84.0 $80,948 - $93,996
1,119 Added 319.71%
1,469 $113,000
Q1 2020

Apr 24, 2020

SELL
$62.63 - $80.22 $3,444 - $4,412
-55 Reduced 13.58%
350 $26,000
Q4 2019

Jan 21, 2020

BUY
$61.62 - $67.78 $3,389 - $3,727
55 Added 15.71%
405 $26,000
Q3 2017

Oct 19, 2017

BUY
$72.11 - $85.47 $25,238 - $29,914
350
350 $28,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $120B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.